|
|
Volumn 25, Issue 5, 2011, Pages 299-304
|
|
Intravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edema.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
ACOUSTIC MICROSCOPY;
ARTICLE;
COMPARATIVE STUDY;
DIABETIC RETINOPATHY;
DOSE RESPONSE;
DRUG ANTAGONISM;
EYE FUNDUS;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
FOLLOW UP;
HUMAN;
INTRAVITREAL DRUG ADMINISTRATION;
LASER COAGULATION;
MALE;
METHODOLOGY;
MIDDLE AGED;
OPTICAL COHERENCE TOMOGRAPHY;
RETINA MACULA EDEMA;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
VISUAL ACUITY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DIABETIC RETINOPATHY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
FOLLOW-UP STUDIES;
FUNDUS OCULI;
HUMANS;
INTRAVITREAL INJECTIONS;
LASER COAGULATION;
MACULAR EDEMA;
MALE;
MICROSCOPY, ACOUSTIC;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
|
|
EID: 84877667266
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2011.25.5.299 Document Type: Article |
|
Times cited : (21)
|
|
References (0)
|
